A comprehensive metabolic evaluation reveals impaired glucose metabolism and dyslipidemia in breast cancer patients early in the disease trajectory

Clinical Nutrition

Volumn 33, Issue 3, 2014, Pages 550-557

  Bell, Kirsten E ^a   Di Sebastiano, Katie M ^a   Vance, Vivienne ^a   Hanning, Rhona ^a   Mitchell, Andrew ^a   Quadrilatero, Joe ^a   Russell, Caryl ^a   Dubin, Joel A ^a   Bahl, Mala ^b   Califaretti, Nadia ^b   Campbell, Carolyn ^b   Mourtzakis, Marina ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b Grand River Regional Cancer Centre   (Canada)

Author keywords

Body composition; C Peptide; Cytokines; Exercise; Insulin; Nutrition

Indexed keywords

C PEPTIDE; CYCLOPHOSPHAMIDE; CYTOKINE; DOCETAXEL; DOXORUBICIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; PACLITAXEL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE BLOOD LEVEL; DIET RESTRICTION; DIETARY INTAKE; DISORDERS OF CARBOHYDRATE METABOLISM; DYSLIPIDEMIA; EXERCISE; FEMALE; FITNESS; GLUCOSE BLOOD LEVEL; HUMAN; ILLNESS TRAJECTORY; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPID BLOOD LEVEL; MULTIPLE CYCLE TREATMENT; MUSCLE STRENGTH; NUTRITIONAL STATUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; BLOOD; BREAST NEOPLASMS; CALORIC INTAKE; COMPLICATION; ENERGY METABOLISM; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MEDICAL RECORD; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; WEIGHT GAIN; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; BREAST NEOPLASMS; C-PEPTIDE; CHOLESTEROL, HDL; CYTOKINES; DIET RECORDS; DYSLIPIDEMIAS; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE STRENGTH; OBESITY; WAIST CIRCUMFERENCE; WEIGHT GAIN; YOUNG ADULT;

EID: 84899627569     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.08.001     Document Type: Article

References (38)

1. Canadian Cancer Statistics 2011 2011 Apr, Canadian Cancer Society.
2. Amaral P., Miguel R., Mehdad A., Cruz C. Body fat and poor diet in breast cancer women. Nutr Hosp 2010, 25(3):456-461.
3. Yaw Y., Kandiah M., Shariff Z., Mun C., Hashim Z., Yusof R., et al. Pattern of weight changes in women with breast cancer. Asian Pac J Cancer Prev 2010 Jan 1, 11:1535-1540.
4. Demark-Wahnefried W., Rimer B., Winer E. Weight gain in women diagnosed with breast cancer. JAm Diet Assoc 1997 May, 97(5):519-529.
5. Vance V., Mourtzakis M., McCargar L., Hanning R. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 2010 Sep 29, 12(4):282-294.
6. Shoelson S., Herrero L., Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007 May, 132(6):2169-2180.
7. Kern P., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001 Mar 22, 280:E745-E751.
8. Bjorge T., Lukanova A., Jonsson H., Tretli S., Ulmer H., Manjer J., et al. Metabolic syndrome and breast cancer in the Me-Can (Metabolic Syndrome and Cancer) Project. Cancer Epidemiol Biomar Prev 2010 Jul 7, 19(7):1737-1745.
9. Goodwin P.J., Panzarella T., Boyd N.F. Weight gain in women with localized breast cancer-a descriptive study. Breast Cancer Res Treat 1988 Apr, 11(1):59-66.
10. Chala E., Manes C., Iliades H., Skaragkas G., Mouratidou D., Kapantais E. Insulin resistance, growth factors and cytokine levels in overweight women with breast cancer before and after chemotherapy. Hormones (Athens) 2006 Apr, 5(2):137-146.
11. Goodwin P., Ennis M., Bahl M., Fantus I. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res 2009, 114:517-525.
12. Ligibel J.A., Campbell N., Partridge A., Chen W.Y., Salinardi T., Chen H., et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. JClin Oncol 2008 Feb 20, 26(6):907-912.
13. Kohrt W.M., Holloszy J.O. Loss of skeletal muscle mass with aging: effect on glucose tolerance. JGerontol A Biol Sci Med Sci 1995 Nov, 50. Spec No:68-72.
14. Barrett-Connor E. Epidemiology, obesity, and non-insulin-dependent diabetes mellitus. Epidemiol Rev 1989, 11:172-181.
15. Moisey L.L., Robinson L.E., Graham T.E. Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males. Br J Nutr 2009 Nov 5, 103(06):833.
16. Lowry O., Passoneau J.A. Flexible system of enzymatic analysis 1972, 146-218. Academic, New York.
17. Duncombe W.G. The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin Chim Acta 1964 Feb, 9:122-125.
18. Jackson A., Pollock M. Practical assessment of body composition. Phys Sports Med 1985 Nov 15, 13:76-90.
19. The American College of Sports Medicine ACSM's guidelines for exercise testing and prescription 2009, Lippincott Williams & Wilkins, Philadelphia. 8th ed.
20. Thompson F.E., Byers T. Dietary assessment resource manual. JNutr 1994 Nov, 124(11 Suppl.):2245S-2317S.
21. Bruera E., Kuehn N., Miller M.J., Selmser P., MacMillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. JPalliat Care 1991, 7(2):6-9.
22. Bell K., Bedbrook M., Nguyen T.T., Mourtzakis M. The facemask produces higher peak minute ventilation and respiratory rate measurements compared to the mouthpiece. JSports Sci Med 2012, 11(3).
23. O'Connor, Simmons J., O'Shea P. Weight training today 1989, West Publishing, St. Paul, MN.
24. Baecke J.A., Burema J., Frijters J.E. Ashort questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982 Nov, 36(5):936-942.
25. Stewart A.L., Mills K.M., King A.C., Haskell W.L., Gillis D., Ritter P.L. CHAMPS physical activity questionnaire for older adults: outcomes for interventions. Med Sci Sports Exerc 2001 Jul, 33(7):1126-1141.
26. Ainsworth B., Haskell W., Leon A., Jacobs D.J., Montoye H., Sallis J., et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993 Feb 3, 25(1):71-80.
27. Brooks G.A., Butte N.F., Rand W.M., Flatt J.-P., Caballero B. Chronicle of the Institute of Medicine physical activity recommendation: how a physical activity recommendation came to be among dietary recommendations. Am J Clin Nutr 2004 May, 79(5):921S-930S.
28. Allison D., Paultre F., Maggio C., Mezzitis N., Pi-Sunyer F. The use of areas under curves in diabetes research. Diabetes 1995, 18(2):245-250.
29. World Health Organization Physical status: the use and interpretation of anthropometry 1995, 1-47. Report of a WHO expert committee. WHO technical report series 854, World Health Organization, Geneva.
30. Alberti K., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med 2006, 23(5):469-480. Wiley Online Library.
31. Eckel R.H., Krauss R.M. American Heart Association Call to action: obesity as a major risk factor for coronary heart disease. Circulation 1998 Jun 2, 97(21):2099-2100.
32. Chan J.M., Rimm E.B., Colditz G.A., Stampfer M.J., Willett W.C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994 Sep, 17(9):961-969.
33. Carter A.C., Lefkon B.W., Farlin M., Feldman E.B. Metabolic parameters in women with metastatic breast cancer. JClin Endocrinol Metab 1975 Feb, 40(2):260-264.
34. Hickish T., Astras G., Thomas P., Penfold S., Purandare L., Hickish T.F., et al. Glucose intolerance during adjuvant chemotherapy for breast cancer. JNatl Cancer I 2009 Mar 24, 101(7):537-547.
35. Weiser M.A., Cabanillas M.E., Konopleva M., Thomas D.A., Pierce S.A., Escalante C.P., et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer 2004 Mar 15, 100(6):1179-1185.
36. Feng J.P., Yuan X.L., Li M., Fang J., Xie T., Zhou Y., et al. Secondary diabetes associated with 5-fluorouracil-based chemotherapy regimens in non-diabetic patients with colorectal cancer: results from a single-centre cohort study. Colorectal Dis 2012 Dec 20, 15(1):27-33.
37. Saruc M., Karaarslan M., Rasa K., Saygili Ö., Ince Ü., Baysal Ç., et al. Pancreatic cancer and glucose metabolism. Turk J Gastroenterol 2009, 20(4):257-260.
38. Fogar P., Pasquali C., Brasso D., Sperti C., Panozzo M.P., Tessari G., et al. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res 1994, 14(6B):2827-2830.